Presented at the European Society for Medical Oncology, study results showed Datroway extended survival in breast cancer ...
Some on Wall Street weren’t too impressed with results from a pivotal trial that tested an Exelixis drug, zanzalintinib, in ...
A closely watched trial in Chinese patients is raising hope that ivonescimab will outperform Keytruda in a large global study ...
Investors reacted positively to news that the company was using a $50 million private placement to help fund a Phase 3 study.
A gene therapy from Regeneron, a pancreatic cancer medicine from Revolution Medicines and a porphyria drug from Disc Medicine ...
Gov. Gavin Newsom signed an array of healthcare bills into law last week that crack down on pharmacy benefit managers and ...
However, if pharma manufacturers aren’t using RWD in a strategic way, they’ll miss out on its full potential. And with that, ...
Study results published in The New England Journal of Medicine show the therapy significantly improved hearing in nearly a ...
Backed by GV and Arch Venture Partners, Pelage Pharmaceuticals is advancing a first-of-its-kind topical gel designed to ...
Shares of Praxis Precision Medicines more than tripled Thursday, peaking at $200 apiece, after the company disclosed positive ...
Some Wall Street analysts have questioned orforglipron’s sales outlook in obesity, but see great potential in diabetes, where ...
The result marks a potential advance for dual-targeting antibody drugs like Tecvayli, which are currently relegated to ...